BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36670097)

  • 1. TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIs.
    Yang C; Jin X; Liu X; Wu G; Yang W; Pang B; Jiang J; Liao D; Zhang Y
    Cell Death Dis; 2023 Jan; 14(1):47. PubMed ID: 36670097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.
    Hu S; Ran Y; Chen W; Zhang Y; Xu Y
    Oncol Rep; 2017 Sep; 38(3):1569-1578. PubMed ID: 28713953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
    Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
    J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells.
    Li H; Xiang Z; Liu Y; Xu B; Tang J
    Oncol Res; 2017 Sep; 25(8):1269-1282. PubMed ID: 28117027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
    Shi H; Fang R; Li Y; Li L; Zhang W; Wang H; Chen F; Zhang S; Zhang X; Ye L
    Cancer Lett; 2016 Nov; 382(2):147-156. PubMed ID: 27609066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
    Wang B; Feng P; Xiao Z; Ren EC
    J Hepatol; 2009 Mar; 50(3):528-37. PubMed ID: 19155088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of EPS8L3 promotes cell proliferation by inhibiting the transactivity of FOXO1 in HCC.
    Zeng CX; Tang LY; Xie CY; Li FX; Zhao JY; Jiang N; Tong Z; Fu SB; Wen FJ; Feng WS
    Neoplasma; 2018 Sep; 65(5):701-707. PubMed ID: 29940761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
    Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis.
    Liu Y; Geng X
    Bioengineered; 2022 Feb; 13(2):3666-3679. PubMed ID: 35081873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27
    Tang Y; Chen J; Li J; Zheng Y; Zhong X; Huang S; Chen B; Peng B; Zou X; Chen X
    Phytomedicine; 2021 Jun; 86():153563. PubMed ID: 33951569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells.
    Hu YT; Shu ZY; Jiang JH; Xie QF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):547-554. PubMed ID: 33051131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway.
    Chi HC; Chen SL; Cheng YH; Lin TK; Tsai CY; Tsai MM; Lin YH; Huang YH; Lin KH
    Cell Death Dis; 2016 Aug; 7(8):e2324. PubMed ID: 27490929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
    Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
    Sun W; Zu S; Shao G; Wang W; Gong F
    J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p.
    Wang S; Xu M; Sun Z; Yu X; Deng Y; Chang H
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G116-G126. PubMed ID: 31021172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
    Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCF19 enhances cell proliferation in hepatocellular carcinoma by activating the ATK/FOXO1 signaling pathway.
    Zeng CX; Fu SB; Feng WS; Zhao JY; Li FX; Gao P
    Neoplasma; 2019 Jan; 66(1):46-53. PubMed ID: 30509085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranslational modifications of FOXO1 regulate epidermal growth factor receptor tyrosine kinase inhibitor resistance for non-small cell lung cancer cells.
    Xu ZH; Shun WW; Hang JB; Gao BL; Hu JA
    Tumour Biol; 2015 Jul; 36(7):5485-95. PubMed ID: 26036758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis.
    You H; Yuan D; Li Q; Zhang N; Kong D; Yu T; Liu X; Liu X; Zhou R; Kong F; Zheng K; Tang R
    Int J Biol Macromol; 2023 Jan; 226():996-1009. PubMed ID: 36473530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
    Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
    J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.